Movement Alert｜Twist Bioscience Falls 5.04% in Pre-Market Trading, Shelf Registration Filing for Up to $200 Million Common Stock Sparks Dilution Concerns

Market Focus06-23 17:11

On June 23, Twist Bioscience fell 5.04% in pre-market trading, trading at $83.57/share, with turnover of $50,400, giving back recent gains.

On the news front, Twist Bioscience filed a shelf registration statement with the U.S. Securities and Exchange Commission last Thursday for the potential sale of securities from time to time in one or more offerings. The filing covers common stock, preferred stock, debt securities, warrants, and units, and includes a prospectus for the sale of up to $200 million of common stock under an at-the-market program. The company stated it intends to use any net proceeds for general corporate purposes. With a total market capitalization of approximately $5.45 billion and roughly 62.27 million shares outstanding, the potential issuance raises meaningful dilution concerns among investors.

Notably, the stock had rallied sharply in recent sessions following Canaccord Genuity's buy rating and $90 price target — significantly above the consensus target of $73.12 — climbing from $85.25 to $87.56 between June 16 and June 18 before the registration filing triggered the current reversal.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192829839?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 17:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192829839","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Falls 5.04% in Pre-Market Trading, Shelf Registration Filing for Up to $200 Million Common Stock Sparks Dilution Concerns","media":"Market Focus","content":"<p><p>On June 23, Twist Bioscience fell 5.04% in pre-market trading, trading at $83.57/share, with turnover of $50,400, giving back recent gains.</p><p>On the news front, Twist Bioscience filed a shelf registration statement with the U.S. Securities and Exchange Commission last Thursday for the potential sale of securities from time to time in one or more offerings. The filing covers common stock, preferred stock, debt securities, warrants, and units, and includes a prospectus for the sale of up to $200 million of common stock under an at-the-market program. The company stated it intends to use any net proceeds for general corporate purposes. With a total market capitalization of approximately $5.45 billion and roughly 62.27 million shares outstanding, the potential issuance raises meaningful dilution concerns among investors.</p><p>Notably, the stock had rallied sharply in recent sessions following Canaccord Genuity's buy rating and $90 price target — significantly above the consensus target of $73.12 — climbing from $85.25 to $87.56 between June 16 and June 18 before the registration filing triggered the current reversal.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Falls 5.04% in Pre-Market Trading, Shelf Registration Filing for Up to $200 Million Common Stock Sparks Dilution Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Falls 5.04% in Pre-Market Trading, Shelf Registration Filing for Up to $200 Million Common Stock Sparks Dilution Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-23 17:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 23, Twist Bioscience fell 5.04% in pre-market trading, trading at $83.57/share, with turnover of $50,400, giving back recent gains.</p><p>On the news front, Twist Bioscience filed a shelf registration statement with the U.S. Securities and Exchange Commission last Thursday for the potential sale of securities from time to time in one or more offerings. The filing covers common stock, preferred stock, debt securities, warrants, and units, and includes a prospectus for the sale of up to $200 million of common stock under an at-the-market program. The company stated it intends to use any net proceeds for general corporate purposes. With a total market capitalization of approximately $5.45 billion and roughly 62.27 million shares outstanding, the potential issuance raises meaningful dilution concerns among investors.</p><p>Notably, the stock had rallied sharply in recent sessions following Canaccord Genuity's buy rating and $90 price target — significantly above the consensus target of $73.12 — climbing from $85.25 to $87.56 between June 16 and June 18 before the registration filing triggered the current reversal.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1192829839","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192829839","pubTimestamp":1782205904,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 23, Twist Bioscience fell 5.04% in pre-market trading, trading at $83.57/share, with turnover of $50,400, giving back recent gains.On the news front, Twist Bioscience filed a shelf...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"动向提示|Twist Bioscience盘前跌5.04%至多2亿美元普通股搁置注册申请引发稀释担忧","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On June 23, Twist Bioscience fell 5.04% in pre-market trading, trading at $83.57/share, with turnover of $50,400, giving back recent gains.On the news front, Twist Bioscience filed a shelf registration statement with the U.S. Securities and Exchange Commission last Thursday for the potential sale of securities from time to time in one or more offerings. The filing covers common stock, preferred stock, debt securities, warrants, and units, and includes a prospectus for the sale of up to $200 million of common stock under an at-the-market program. The company stated it intends to use any net proceeds for general corporate purposes. With a total market capitalization of approximately $5.45 billion and roughly 62.27 million shares outstanding, the potential issuance raises meaningful dilution concerns among investors.Notably, the stock had rallied sharply in recent sessions following Canaccord Genuity's buy rating and $90 price target — significantly above the consensus target of $73.12 — climbing from $85.25 to $87.56 between June 16 and June 18 before the registration filing triggered the current reversal.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192829839","isCrawlerRequest":true}